These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. Eshleman SH; Piwowar-Manning E; Sivay MV; Debevec B; Veater S; McKinstry L; Bekker LG; Mannheimer S; Grant RM; Chesney MA; Coates TJ; Koblin BA; Fogel JM J Clin Virol; 2018; 99-100():67-70. PubMed ID: 29346085 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253 [TBL] [Abstract][Full Text] [Related]
8. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology. de Souza MS; Pinyakorn S; Akapirat S; Pattanachaiwit S; Fletcher JL; Chomchey N; Kroon ED; Ubolyam S; Michael NL; Robb ML; Phanuphak P; Kim JH; Phanuphak N; Ananworanich J; Clin Infect Dis; 2016 Aug; 63(4):555-61. PubMed ID: 27317797 [TBL] [Abstract][Full Text] [Related]
9. Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation. Crowell TA; Ritz J; Coombs RW; Zheng L; Eron JJ; Mellors JW; Dragavon J; van Zyl GU; Lama JR; Ruxrungtham K; Grinsztejn B; Arduino RC; Fox L; Ananworanich J; Daar ES; Clin Infect Dis; 2021 Aug; 73(3):e643-e651. PubMed ID: 33382405 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens. Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437 [TBL] [Abstract][Full Text] [Related]
11. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection. Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I. Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay. Luo W; Davis G; Li L; Shriver MK; Mei J; Styer LM; Parker MM; Smith A; Paz-Bailey G; Ethridge S; Wesolowski L; Owen SM; Masciotra S J Clin Virol; 2017 Jun; 91():84-89. PubMed ID: 28366544 [TBL] [Abstract][Full Text] [Related]
14. Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand. Ananworanich J; Eller LA; Pinyakorn S; Kroon E; Sriplenchan S; Fletcher JL; Suttichom D; Bryant C; Trichavaroj R; Dawson P; Michael N; Phanuphak N; Robb ML J Int AIDS Soc; 2017 Jun; 20(1):21652. PubMed ID: 28691436 [TBL] [Abstract][Full Text] [Related]
15. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma. Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy. Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173 [TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens. Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891 [TBL] [Abstract][Full Text] [Related]
19. Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test. Jagodzinski LL; Manak MM; Hack HR; Liu Y; Malia JA; Freeman J; Phanuphak N; de Souza M; Kroon ED; Colby DJ; Chomchey N; Lally MA; Michael NL; Ananworanich J; Peel SA; J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842229 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection. Cárdenas AM; Baughan E; Hodinka RL J Clin Virol; 2013 Dec; 58 Suppl 1():e97-e103. PubMed ID: 24113294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]